Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wunderlich

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Cancer Discovery|September 17, 2021
An <i>In Vivo</i> CRISPR Screening Platform for Prioritizing Therapeutic Targets in AMLShan Lin, Clément Larrue, Nastassja K Scheidegger, et al.
Nature Biotechnology|January 26, 2023
In vivo development of immune tissue in human intestinal organoids transplanted into humanized miceCarine Bouffi, Kathryn A Wikenheiser-Brokamp, Praneet Chaturvedi, et al.
Cancer Cell|April 17, 2019
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid LeukemiaYue Huang, Rui Su, Yue Sheng, et al.
Cell|December 18, 2024
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignanciesZhenhua Chen, Chengwu Zeng, Lu Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemiaPing Chen, Colles Price, Zejuan Li, et al.
Blood Advances|May 5, 2026
Combining Menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemiaNastassja Keora Scheidegger, Constanze Schneider, Gabriela Alexe, et al.
Cell Stem Cell|January 2, 2018
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m<sup>6</sup>A ModificationHengyou Weng, Huilin Huang, Huizhe Wu, et al.
Cell Stem Cell|January 7, 2023
METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolismLi Han, Lei Dong, Keith Leung, et al.
Science Translational Medicine|September 6, 2019
Overcoming adaptive therapy resistance in AML by targeting immune response pathwaysKatelyn Melgar, Morgan M Walker, LaQuita M Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
TET1 plays an essential oncogenic role in MLL-rearranged leukemiaHao Huang, Xi Jiang, Zejuan Li, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Cancer Discovery|September 17, 2021
An <i>In Vivo</i> CRISPR Screening Platform for Prioritizing Therapeutic Targets in AMLShan Lin, Clément Larrue, Nastassja K Scheidegger, et al.
Nature Biotechnology|January 26, 2023
In vivo development of immune tissue in human intestinal organoids transplanted into humanized miceCarine Bouffi, Kathryn A Wikenheiser-Brokamp, Praneet Chaturvedi, et al.
Cancer Cell|April 17, 2019
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid LeukemiaYue Huang, Rui Su, Yue Sheng, et al.
Cell|December 18, 2024
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignanciesZhenhua Chen, Chengwu Zeng, Lu Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemiaPing Chen, Colles Price, Zejuan Li, et al.
Blood Advances|May 5, 2026
Combining Menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemiaNastassja Keora Scheidegger, Constanze Schneider, Gabriela Alexe, et al.
Cell Stem Cell|January 2, 2018
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m<sup>6</sup>A ModificationHengyou Weng, Huilin Huang, Huizhe Wu, et al.
Cell Stem Cell|January 7, 2023
METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolismLi Han, Lei Dong, Keith Leung, et al.
Science Translational Medicine|September 6, 2019
Overcoming adaptive therapy resistance in AML by targeting immune response pathwaysKatelyn Melgar, Morgan M Walker, LaQuita M Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
TET1 plays an essential oncogenic role in MLL-rearranged leukemiaHao Huang, Xi Jiang, Zejuan Li, et al.
Pageof 12